To examine the degree to which the improvement in TTR associated with RL-consistent dosing might translate into reductions in stroke and other events, we developed a multilevel, multivariable Cox proportional hazard model to examine the relationship between center-level algorithm-consistency and a composite outcome of stroke, systemic embolism, or major hemorrhage (Table 3). This evidence concerns the gene TTR and Stroke.